Alexis Kozlowski, APRN
Family · Rockford, ILNPI 1104697036
Payments from drug & device makers
Across 85 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$279
- Novo Nordisk$265
- AstraZeneca$143
- GSK$138
- Boehringer Ingelheim$129
- Lilly USA, LLC$119
- plus $569 from 15 others
What the payments were for
- Food & beverage$1,642100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $279 |
| Novo Nordisk | 12 | $265 |
| AstraZeneca | 8 | $143 |
| GSK | 6 | $138 |
| Boehringer Ingelheim | 7 | $129 |
| Lilly USA, LLC | 7 | $119 |
| Esperion Therapeutics, Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Bayer | 4 | $68 |
| Lundbeck LLC | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Exact Sciences | 2 | $35 |
| Angiodynamics, Inc. | 1 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Surgenex LLC | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
How this compares
$1,642 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $8,750 |
| Atorvastatin Calcium | 83 | $1,177 |
| Pantoprazole Sodium | 67 | $1,104 |
| Potassium Chloride | 43 | $1,023 |
| Gabapentin | 56 | $1,019 |
| Trazodone Hcl | 39 | $875 |
| Levothyroxine Sodium | 75 | $856 |
| Tamsulosin Hcl | 42 | $733 |
| Metoprolol Succinate | 30 | $649 |
| Sertraline Hcl | 40 | $629 |
| Donepezil Hcl | 40 | $580 |
| Mirtazapine | 17 | $574 |
| Amlodipine Besylate | 67 | $546 |
| Duloxetine Hcl | 17 | $541 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $464 |
Paid to pharmacies, not to this prescriber.
Other family in Rockford
- Suzanne Artale-FritzRockford$63K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.